No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Biocad’s Pertuzumab Biosimilar Approved in Russia
On 28 May 2025, Russia’s GxP News reported that the Russian Ministry of Health approved Russian biotechnology company Biocad’s Pertuvia™, biosimilar to Roche’s Perjeta® (pertuzumab), making it…